PHARMATROPHIX
San Francisco's PharmatrophiX, a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
PHARMATROPHIX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.pharmatrophix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.83 M USD
Technology used in webpage:
Google Font API Euro Google Plus One Button TinyMCE Google Plus One Share Button Web.com
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Dolby Family Ventures
Dolby Family Ventures investment in Debt Financing - PharmatrophiX
Official Site Inspections
http://www.pharmatrophix.com
- Host name: 209.17.116.160
- IP address: 209.17.116.160
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "PharmatrophiX"
Pharmatrophix Team
As CEO of PharmatrophiX, Ms. Longo develops and executes funding models, oversees finances working with the CFO, manages commercial projects and supervises contract research organization (CRO) projects. She has worked in …See details»
PharmatrophiX - Crunchbase Company Profile & Funding
San Francisco's PharmatrophiX, a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class …See details»
Pharmatrophix Company Profile | Management and Employees …
Pharmatrophix Profile and History PharmatrophiX, Inc. is a biopharmaceutical company that develops disease modifying small molecule drugs for neurodegenerative and other disorders. …See details»
Pharmatrophix Company Profile 2024: Valuation, …
Pharmatrophix was founded in 2005. Where is Pharmatrophix headquartered? Pharmatrophix is headquartered in Menlo Park, CA. What is the size of …See details»
PharmatrophiX - The Org
PharmatrophiX is a biotech company focused on developing therapeutic drugs to prevent neurodegenerative diseases.See details»
Pharmatrophix - Company Profile - Tracxn
Nov 27, 2024 Pharmatrophix - Small molecule therapeutics for neurodegenerative diseases. Raised a total funding of $11M over 5 rounds. Pharmatrophix has 520 competitors.See details»
PharmatrophiX - Products, Competitors, Financials, Employees ...
PharmatrophiX is a clinical-stage biopharmaceutical company focused on the development of disease-modifying small molecule drugs for neurodegenerative and other disorders. The …See details»
PHARMATROPHIX, INC. Company Profile | Menlo Park, CA
Find company research, competitor information, contact details & financial data for PHARMATROPHIX, INC. of Menlo Park, CA. Get the latest business insights from Dun & …See details»
PharmatrophiX - Crunchbase
PharmatrophiX is a biotech company focused on developing therapeutic drugs to prevent neurodegenerative diseases.See details»
PharmatrophiX Company Profile - Office Locations, Competitors
PharmatrophiX is a company developing small molecule drugs for neurodegenerative and other diseases. It uses a PTX technology to create drugs modulating neurotrophin receptor …See details»
PharmatrophiX | Alzheimer's Drug Discovery Foundation
PharmatrophiX is a clinical-stage company developing a small molecule, LM11A-31-BHS, targeting a cell surface receptor and signaling networks that regulate cellular pathways and …See details»
PharmatrophiX | Alzheimer's Drug Discovery Foundation
Jul 1, 2013 PharmatrophiX (PTX) is a virtual biotech company founded by Dr. Longo in 2005 and is focused on the development of small molecule ligands directed to neurotrophin receptors for …See details»
Pharmatrophix - Overview, News & Similar companies - ZoomInfo
PharmatrophiX, Inc. is a biopharmaceutical company that develops disease modifying small molecule drugs for neurodegenerative and other disorders. PTX technology helps in …See details»
PharmatrophiX | Alzheimer's Drug Discovery Foundation
PharmatrophiX (PTX) was founded by Professor Frank Longo, Chairman of the Department of Neurology and Neurological Sciences at Stanford University, through the ADDF Biotechnology …See details»
PharmatrophiX - Contacts, Employees, Board Members, Advisors …
PharmatrophiX is a biotech company focused on developing therapeutic drugs to prevent neurodegenerative diseases.See details»
Pharmatrophix Peer Reviewed Funding
In 2016 PharmatrophiX was awarded a peer-reviewed NIH/National Institute of Aging Alzheimer’s Disease Pilot Clinical Trial Award to provide support for its current phase 2a exploratory …See details»
PharmatrophiX | VentureRadar
Similar Companies: Qurient South Korea Publicly Traded Qurient is a spin-off biotechnology company from the Institute Pasteur Korea (IPK) dedicated to developing novel therapeutics …See details»
PharmatrophiX - Funding, Financials, Valuation & Investors
Organization. PharmatrophiX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 5. obfuscated. …See details»
PTX technology - Pharmatrophix
Neurotrophin receptors on the surface of neurons are potent regulators of signaling networks that determine whether a neuron or its synapse survives or degenerates.See details»